Pulmonology Advisor is a comprehensive resource for healthcare professionals focused on pulmonary and critical care medicine.
Loading...
Among patients hospitalized with #influenza, more than half had signs of left ventriculrar dysfunction or #RightVentricularDysfunction. #PulmSky #CardioSky
Although people with #CysticFibrosis are bothered less by symptoms now vs before starting elexacaftor/tezacaftor/ivacaftor (ETI), bothersome symptoms are still reported, especially among older adults.
From @jacionline.bsky.social 🥜
Early-life peanut #OralImmunotherapy may provide long-term clinical and immunologic benefits for children with #PeanutAllergies.
@jhu.edu
@stanfordmedicine.bsky.social
#CFTRModulator therapies reduce the long-term risk of death in patients with #CysticFibrosis. #PulmSky
@accpchest.bsky.social
From @lancetrespirmed.bsky.social :
Considerable variation in #ventilation practice occurs in critically ill children with and without pediatric #AcuteRespiratoryDistressSyndrome.
From @lancetrespirmed.bsky.social :
Azurocidin-1 (AZU1) is a marker of severity in #bronchiectasis and #ChronicObstructivePulmonaryDisease.
From @lancetrespirmed.bsky.social 🫁
The link between 60-day mortality and personalized, best-practice mechanical ventilation in patients with #AcuteRespiratoryDistressSyndrome may be stronger in those with hypoinflammatory vs hyperinflammatory ARDS.
Inhaled #corticosteroid-containing inhalers are commonly prescribed to patients after acute #RespiratoryTractInfections, frequently without objective diagnostic evaluation. #PulmSky
A #MachineLearning-based model may aid in-hospital #CommunityAcquiredPneumonia mortality prediction. #PulmSky
From @jacionline.bsky.social 🫁
#Tezepelumab is associated with clinical remission at week 52 in about one-third of patients with severe #asthma and has favorable safety and tolerability. #PulmSky
The link between 60-day mortality and MV in patients with ARDS may be stronger in those with hypoinflammatory vs hyperinflammatory ARDS.
